Epidermal growth factor receptor expression in primary laryngeal cancer: An independent prognostic factor of neck node relapse
dc.contributor.author | Almadori, G. | en |
dc.contributor.author | Cadoni, G. | en |
dc.contributor.author | Galli, J. | en |
dc.contributor.author | Ferrandina, G. | en |
dc.contributor.author | Scambia, G. | en |
dc.contributor.author | Exarchakos, G. | en |
dc.contributor.author | Paludetti, G. | en |
dc.contributor.author | Ottaviani, F. | en |
dc.date.accessioned | 2015-11-24T19:18:51Z | |
dc.date.available | 2015-11-24T19:18:51Z | |
dc.identifier.issn | 0020-7136 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21904 | |
dc.rights | Default Licence | - |
dc.subject | squamous-cell carcinomas | en |
dc.subject | dissection | en |
dc.subject | survival | en |
dc.title | Epidermal growth factor receptor expression in primary laryngeal cancer: An independent prognostic factor of neck node relapse | en |
heal.abstract | Specimens of laryngeal squamous cell carcinoma (LSCC) were examined for epidermal growth factor receptor (EGFR) content using a radioreceptor method; 140 untreated consecutive patients with primary LSCC undergoing initial surgical resection were followed up for a median of 49 months (range 2-84 months) after surgery. Cox univariate regression analysis using EGFR as a continuous variable showed that EGFR levels were directly associated with the risk of lymph node metastasis, A significant relationship between EGFR status and cervical node metastasis was observed. The cutoff value of 20 fmol/mg protein was the best prognostic discriminator. The 5-year metastasis-free survival (MFS) was 66% for patients with EGFR(-) tumors compared with 15% for patients with EGFR(+) tumors. By multivariate analysis, the EGFR status appeared to be a significant independent prognostic factor for MFS. Our results suggest that the assessment of EGFR status at the time of diagnosis may identify a subset of LSCC patients highly susceptible to neck node metastases thus defining therapy accordingly. Int. J. Cancer (Pred. Oncol.) 84:188-191, 1999. in 1999 Wiley-Liss, Inc. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.secondary | <Go to ISI>://000079167700016 | - |
heal.journalName | International Journal of Cancer | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 1999 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: